Search Results

Sri Kosuri Sri is a biologist that has helped build technologies, labs, and companies in synthetic biology , functional genomics, and bioinformatics over the last 20 years. He is passionate about developing more rational ways to understand and engineer biology. , human genetic variation, gene regulation, chemical biology, synthetic biology, and functional genomics at MIT and BS in Bioengineering at UC Berkeley.

Following this tremendous experience, he was recruited to be the Principal Investigator of the Receptor Biology To broaden his biomedical skill-set Stuart next accepted the position of Head of the Receptor Pharmacology Adjunct Director of the VIB Center for Molecular Neurology and also Vice-Chair of the Department of Biomedical Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based Maudsley on the web Maudsley Lab LinkedIn Google Scholar ResearchGate Maudsley Lab on Facebook Receptor Biology

melanocortin receptor accessory protein 2 (MRAP2), resulting in my first peer-reviewed publication in Biochimica et Biophysica Acta (BBA). In 2017 I officially joined the PhD program in the Department of Molecular Physiology and Biophysics While writing my thesis, I published another paper in the Journal of Biological Chemistry which described At this point in my career, I am creating connections with biomedical industry, assessing professional

She completed her undergraduate education at Providence College, receiving a B.S. in Biology and a B.A Victoria started her Ph.D. at the Tri-Institutional Ph.D. program in Chemical Biology, where she joined as a therapeutic strategy. " Victoria Rasmussen on the web Tri-Institutional PhD Program in Chemical Biology GPCR About Madelyn Moore "Madelyn (Maddi) earned her B.S. in Biochemistry from the University of Minnesota-Duluth Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Gabriele Kockelkoren About Gabriele Kockelkoren I have a strong background in both physics and molecular biology Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Antony Boucard joined the Université de Sherbrooke (Québec, Canada) as a B.S. student of the Biochemistry cardiovascular system by investigating the structure of the Angiotensin and Urotensin receptors through various biochemical Mexico City to establish himself as an independent investigator integrating the department of Cell Biology Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Premont obtained his B.S. in Biology and Chemistry at the California Institute of Technology in 1985, and M.Ph . and Ph.D. in Biomedical Sciences (Pharmacology) at Mount Sinai School of Medicine (City University In our work, we utilize methods including structural biology and proteomics, molecular biology and biochemical Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

After earning her undergraduate degree in biochemistry from the University of Michigan, she deferred Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Gloriam About this episode David Gloriam is a Professor in Computational Receptor Biology at the University David obtained his Ph.D. from Uppsala University in Sweden where he worked on the bioinformatic identification He completed two postdocs in the UK at the EMBL-European Bioinformatics Institute and GlaxoSmithKline Gloriam on the web LinkedIn ResearchGate Twitter Google Scholar Computation Receptor Biology- Gloriam Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

He is Chief Scientific Officer and co-founder of InterAx Biotech, where he specializes in the development He also worked on creating novel methods for systems biology using temporal logic specifications while conversation about the importance of merging mathematical models and biology. his experiences transitioning from academia into the biotech sector. and relevance of mathematical models in systems biology and pharmacology.

Gregory Tall earned his Ph.D. in Biomedical Sciences from U.T. Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Premont obtained his B.S. in Biology and Chemistry at the California Institute of Technology in 1985, and M.Ph . and Ph.D. in Biomedical Sciences (Pharmacology) at Mount Sinai School of Medicine (City University In our work, we utilize methods including structural biology and proteomics, molecular biology and biochemical Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

a productive, independent scientific research career in adhesion G protein-coupled receptor (aGPCR) biology linked to various neuropsychiatric phenotypes, and my work will provide a basis for understanding aGPCR biology Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Neuroscience, and Artificial Intelligence and Human Health, as well as the Dean of The Graduate School of Biomedical To this end, her lab uses several computational structural biology tools and rational drug design approaches , ranging from molecular modeling, bioinformatics, cheminformatics, molecular dynamics simulations, free-energy in Computational Chemistry at the Second University of Naples and a postdoctorate in Computational Biophysics Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Ben Holland About Murat Tunaboylu "Murat Tunaboylu, Antiverse's CEO, has a software engineering and bioinformatics After switching to biotech, Murat has built cell imaging software and lab robots to accelerate cancer He has co-founded consultancy and biotech companies Svarlight and Antiverse. Murat Tunaboylu on the web Antiverse DSV Future of Drug Discovery Podcast Twist Bioscience LinkedIn Twitter Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

tissue-specific engagement Who should listen Navigated complex datasets where interpretation depended on biological His group develops imaging and chemical biology tools to reveal how GLP-1 and GIP receptors operate within David Hodson on the Web Radcliffe Department of Medicine Islet Biology Lab University of Birmingham Upcoming Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

contributed to the discovery or development of 5 marketed drugs through his work spanning molecular, biochemical Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Gilchrist completed her Ph.D. in Biomedical Sciences / Immunology at the University of Connecticut and Annette worked in industry, academia and her entrepreneurial side led her to three companies, Cue Biotech , Caden Biosciences , and MyGenomeRx in addition to being a consultant for over a decade. Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

How academia and biotech collaborate to scale GPCR tools—covering fluorescence assays, GPCR internalization GPCR Podcast , leaders from academia and biotech unpack what effective collaboration really looks like Together, we discuss how gpcr drug discovery advances when chemists, biologists, and industry partners Maria Majellaro is the Chief Scientific Officer and co-founder of Celtarys Research , a biotech spin-off Her work centers on GPCR modulators, synthetic chemistry, and enabling robust biological assays through

Sudha Shenoy is currently an Associate Professor in Medicine & Cell Biology in the Division of Cardiovascular Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Biotech founder Ajay Yekkirala shares how AI, GPCRs, and bold questions are driving next-gen pain therapeutics Ajay Yekkirala is a GPCR pharmacologist, biotech entrepreneur, and co-founder of Superluminal Medicines AI is reshaping how we understand protein dynamics , but only when driven by deep biological questions GPCR scientists interested in translational innovation Biotech investors and strategic leaders seeking Ajay’s work sits at the intersection of GPCR biology, AI, and translational medicine.

Initially driven by a general passion for biology and a childhood dream of being an astronaut, he began “The goal is to smash all the amazing biology together and make a drug.” Structural Biology Roadblocks: The Cryo-EM Challenge One bottleneck in Ben’s work is visualizing binding Still, by collaborating with structural biology teams and combining cryo-EM with NMR , his lab is narrowing Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Graeme Milligan Professor Graeme Milligan is Gardiner Professor of Biochemistry, Dean of Research, and Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

studies the unusual signaling mechanisms employed by these atypical 7-transmembrane receptors, combining biochemical and structural approaches with cell biology and in vivo models. Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

biased agonism, and incorporates computational and mathematical modelling, structural and chemical biology competitive, charitable and commercial sources, as well as being academic co-founder of three GPCR-focussed biotechnology & Toxicology’, and in 2021 also named him a Highly Cited Researcher in the additional category of ‘Biology & Biochemistry’. They also emphasized the significance of fundamental discoveries, the role of biotech, and the need for